Talphera Inc - Company Profile

All the sales intelligence you need on Talphera Inc in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Talphera Inc fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Talphera Inc.

Talphera Inc: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 11+ results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	20 Sep 2017	Lorem
AcelRx to enroll 160 additional patients in two Phase III pain studies based on FDA discussions - exec	09 Feb 2016	Alissa Fleck
AcelRx’s Zalviso device use draws caution over EMA approval in moderate-to-severe acute pain - experts	05 Jun 2015	Jennifer C. Smith-Parker, Hamish McDougall
MedCo’s FDA approval chances for Ionsys post-op pain hinges on human factor studies - experts	11 Mar 2015	Hamish McDougall,

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Talphera Inc and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer